DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Verbeke L, Mannaerts I, Schierwagen R. et al.
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Sci Rep 2016;
6: 33453
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.